The African Program for @entity7289 Control (APOC) was launched in 1995 with the main goal being to boost the fight against @entity7289 in Africa. In 2011, over 80 million @entity1 benefited from this intervention thanks to the contribution of 268.718 @entity497 ( @entity497 ). These significant results obscure the role of @entity1 @entity497 in this fight. Indeed, the insufficient involvement of female @entity497 has been identified as a concern by the APOC partners early in the program. The present study aims to assess the contribution and performance of @entity1 involved in a strategy to control @entity7289 by community-directed treatment with @entity3070 in sub Saharan Africa. We searched the following electronic databases from January 1995 to July 2013: Medline, Embase (Excerpta Medica Database), @entity7184 ( @entity7184 ), LILAS (Latin American and Caribbean Literature on Health Sciences), International Bibliography of Social Sciences, Social Services Abstracts, and Sociological Abstracts. Two research team members independently conducted data extraction from the final sample of articles by using a pre-established data extraction sheet. The primary outcome was the contribution of female @entity497 in the control of @entity7289 by community-directed treatment with @entity3070 . Of 25 hits, 7 papers met the inclusion criteria. For the management of @entity7289 , female CDDs are elected by the health committee from the communities they will serve. The significant proportion of those treated (about 61%) were @entity1 , although only 24% of CDDs were @entity1 . Many community members reported that @entity1 were more committed, persuasive and more @entity1 than @entity1 in the distribution of @entity3070 . Some studies have identified underutilization of female @entity497 as one reason for the limited effectiveness or, in some cases, pure failure related to the distribution of @entity3070 interventions in the fight against @entity7289 in sub-Saharan Africa. Evidence from this review suggests that female @entity497 contribute to the treatment of @entity7289 with @entity68487 in sub-Saharan Africa. Large-scale rigorous studies including Randomized controlled trials (RCTs) are needed to compare Community-Directed intervention involving @entity1 and @entity1 CDDs.

Contribution and performance of female @entity497 in the treatment of XXXX with @entity3070 in Sub-Saharan Africa: a systematic review.

@entity1 :: ('9606', 'Species') :: ['women', 'people', 'patient', 'men'] @entity3070 :: ('MESH:D007559', 'Chemical') :: ['ivermectin', 'Ivermectin'] @entity7184 :: ('MESH:D012090', 'Disease') :: ['CINAHL', 'Cumulative Index to Nursing and Allied Health Literature'] @entity68487 :: ('CHEBI:6078', 'Chemical') :: ['Ivermectine'] @entity497 :: ('MESH:D003147', 'Disease') :: ['Community-Directed Distributors', 'CDD'] @entity7289 :: ('MESH:D009855', 'Disease') :: ['onchocerciasis', 'Onchocerciasis']
@entity7289 :: (MESH:D009855,Disease) :: ['onchocerciasis']
